Cover image of the article: Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects

Image Credit:J Rep Pharm Sci

Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects

Authors

Marzieh Rahmani Khajouei1, 2, Ahmad Mohammadi-Farani3, Hamid Ghorbani2, 4, Alireza Aliabadi2,*
1Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
3Department of Pharmacology, Toxicology and Medical Services, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email:aliabadi.alireza@gmail.com

Journal of Reports in Pharmaceutical Sciences:Vol. 4, issue 2; 162-171
Published online:Aug 31, 2015
Article type:Research Article
Received:Apr 14, 2015
Accepted:Jul 28, 2015
How to Cite:Rahmani Khajouei M, Mohammadi-Farani A, Ghorbani H, Aliabadi A. Synthesis and Acetylcholinesterase Inhibitory Assessment of 3-(2-(4-benzoylpiperazin-1-yl) ethylimino) indolin-2-one Derivatives with Potential Anti-Alzheimer Effects. J Rep Pharm Sci. 2015;4(2):e147677. doi:

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder in geriatric people that characterized by reduction in memory and learning ability. Attenuation of cholinergic system is the most likely hypothesis. Therefore, potentiation of the cholinergic system via inhibition of acetylcholinesterase enzyme could improve and alleviate the symptoms of AD. A new series of isatin-based derivatives (4a-4h) were designed and synthesized according to the pharmacophore of donepezil and consequently related anti-cholinesterase effect was evaluated by Ellman's test. Obtained results were compared with donepezil as a standard drug. All of target derivatives (4a-4h) synthesized with moderate yields. In Ellman's test as an enzymatic assay for acetylcholinesterase, the most of them displayed better inhibitory potency in comparison with donepezil. In summary, isatin-based derivatives could be potential anti-Alzheimer agents. But, more experimental investigations are needed to prove this statement in the future.

Highlights

Copyright

© 2015, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2016
Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(1,3-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents

Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(1,3-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents

Ahmad Mohammadi-Farani,
Samira Soltani Darbandi,
Alireza Aliabadi

Mohammadi-Farani A, Soltani Darbandi S, Aliabadi A. Synthesis and Acetylcholinesterase Inhibitory Evaluation of 4-(1,3-Dioxoisoindolin-2-yl)-N-Phenyl Benzamide Derivatives as Potential Anti-Alzheimer Agents. Iran J Pharm Res. 2016;15(3):e125144. doi: https://doi.org/10.22037/ijpr.2016.1868

8
Jan
2017
Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice

Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice

Marzieh Rahmani Khajouei,
Ahmad Mohammadi-Farani,
Daryoush Mirzaei,
Alireza Aliabadi

Rahmani Khajouei M, Mohammadi-Farani A, Mirzaei D, Aliabadi A. Isatin-Based Anticonvulsant Agents Synthesis and Antiseizure Evaluation in Mice. J Rep Pharm Sci. 2017;6(1):e147618. doi:

16
Jul
2017
Synthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects

Synthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects

Alireza Aliabadi,
Ahmad Mohammadi-Farani,
Mohammad Javad Ahmadvand,
marzieh Rahmani Khajouei

Aliabadi A, Mohammadi-Farani A, Ahmadvand MJ, Rahmani Khajouei M. Synthesis, docking and acetylcholinesterase inhibitory evaluation of (E)-3-(4-(diethylamino) phenyl)-1-phenylprop- 2-en-1-one derivatives with probable anti-Alzheimer effects. J Rep Pharm Sci. 2017;6(2):e147611. doi:

16
Aug
2026
Design, Synthesis, Molecular Dynamics Analysis, and Biological Evaluation of New Urea Derivatives in an Animal Model of Alzheimer Disease

Design, Synthesis, Molecular Dynamics Analysis, and Biological Evaluation of New Urea Derivatives in an Animal Model of Alzheimer Disease

Sara Heidarian,
Mehrdad Faizi,
Mehrdad Alemi,
Amir Garmabdari,
Noushin Nikray,
Mona Khoramjouy
,et al.

Heidarian S, Faizi M, Alemi M, Garmabdari A, Nikray N, et al. Design, Synthesis, Molecular Dynamics Analysis, and Biological Evaluation of New Urea Derivatives in an Animal Model of Alzheimer Disease. Iran J Pharm Res. 2026;25(1):e172672. doi: https://doi.org/10.5812/ijpr-172672

20
Nov
2010
Synthesis and Antimicrobial Activity of Some New Isatin Derivatives

Synthesis and Antimicrobial Activity of Some New Isatin Derivatives

Ankur Patel,
Sanjaykumar Bari,
Gokul Talele,
Jitendra Patel,
Manda Sarangapani

Patel A, Bari S, Talele G, Patel J, Sarangapani M. Synthesis and Antimicrobial Activity of Some New Isatin Derivatives. Iran J Pharm Res. 2022;5(4):e128295. doi: https://doi.org/10.22037/ijpr.2010.685

More by these authors

Marzieh Rahmani KhajoueiPubMedScholar
Ahmad Mohammadi-FaraniPubMedScholar
Hamid GhorbaniPubMedScholar
Alireza AliabadiPubMedScholar
Share
Cited by
Metrics